Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $556.6900 (1.64%) ($550.0000 - $561.2400) on Tue. Nov. 3, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.19% (three month average) | RSI | 32 | Latest Price | $556.6900(1.64%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.9% a day on average for past five trading days. | Weekly Trend | REGN declines -3.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) XLV(43%) SPLV(37%) IVW(36%) SPY(36%) | Factors Impacting REGN price | REGN will decline at least -1.095% in a week (0% probabilities). VIXM(-21%) TBT(-8%) VXX(-7%) UUP(-6%) EDOC(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.095% (StdDev 2.19%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $579.85 | 5 Day Moving Average | $554.42(0.41%) | 10 Day Moving Average | $566.13(-1.67%) | 20 Day Moving Average | $579.85(-3.99%) | To recent high | -14% | To recent low | 2.4% | Market Cap | $59.025b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |